NasdaqGM - Nasdaq Real Time Price USD

Cerus Corporation (CERS)

1.5100

+0.1300

+(9.42%)

At close: June 6 at 4:00:01 PM EDT

1.5100

0.00

(0.00%)

Pre-Market: 8:37:54 AM EDT

3 Promising Penny Stocks With Market Caps Over $90M

The market has been flat over the last week, but it has shown a 13% rise over the past year, with earnings projected to grow by 14% annually in the coming years. In this context, identifying promising stocks involves looking for those that combine affordability with solid financials. While penny stocks might seem like an outdated term, they remain relevant as they often represent smaller or newer companies offering potential growth opportunities.

Simply Wall St. 5 days ago

CERS
+9.42%

CATX

BMEA
Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

CONCORD, Calif., June 03, 2025--Cerus Corporation (Nasdaq: CERS) announced today that members of the management team are scheduled to present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 in Miami, Florida, on Wednesday, June 11, 2025, at 8:40 a.m. Eastern Time.

Business Wire 5 days ago

CERS
+9.42%
Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan

CONCORD, Calif., May 29, 2025--Cerus Corporation (Nasdaq: CERS) today announced it will showcase the latest INTERCEPT Blood System clinical data at the 35th Regional International Society of Blood Transfusion (ISBT) Congress being held May 31 to June 4, 2025, in Milan.

Business Wire 11 days ago

CERS
+9.42%
Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device

CONCORD, Calif., May 28, 2025--Cerus Corporation (Nasdaq: CERS) announced today two in-country regulatory approvals for INT200, one by the French National Agency for Medicines and Health Product Safety (ANSM) and the other by the Swiss Agency for Therapeutic Products (Swissmedic).

Business Wire 12 days ago

CERS
+9.42%
When Should You Buy Cerus Corporation (NASDAQ:CERS)?

While Cerus Corporation ( NASDAQ:CERS ) might not have the largest market cap around , it received a lot of attention...

Simply Wall St. 16 days ago

CERS
+9.42%
Cerus Corporation (NASDAQ:CERS) Just Reported, And Analysts Assigned A US$4.25 Price Target

Cerus Corporation ( NASDAQ:CERS ) came out with its quarterly results last week, and we wanted to see how the business...

Simply Wall St. last month

CERS
+9.42%
Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates

Cerus (CERS) delivered earnings and revenue surprises of 20% and 2.95%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

CERS
+9.42%
Cerus: Q1 Earnings Snapshot

CERS) on Thursday reported a loss of $7.7 million in its first quarter. On a per-share basis, the Concord, California-based company said it had a loss of 4 cents. The biomedical products company posted revenue of $43.2 million in the period.

Associated Press Finance last month

CERS
+9.42%
Cerus Corporation Announces First Quarter 2025 Financial Results

CONCORD, Calif., May 01, 2025--Cerus Corporation (Nasdaq: CERS) announced today financial results for the first quarter ended March 31, 2025, and provided a business update.

Business Wire last month

CERS
+9.42%
With 64% ownership, Cerus Corporation (NASDAQ:CERS) boasts of strong institutional backing

Key Insights Institutions' substantial holdings in Cerus implies that they have significant influence over the...

Simply Wall St. last month

CERS
+9.42%
Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025

CONCORD, Calif., April 17, 2025--Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2025 financial results will be released on Thursday, May 1, 2025, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company’s financial results and provide a general business overview and outlook.

Business Wire last month

CERS
+9.42%
Cerus Leads Our Selection Of 3 Promising Penny Stocks

As U.S. stocks attempt to recover from recent downturns, with the S&P 500 and Nasdaq aiming to end their losing streaks, investors are navigating a market filled with uncertainty yet ripe with potential opportunities. Penny stocks, though often overlooked in favor of more established names, remain an intriguing investment area for those seeking growth in smaller or newer companies. By focusing on firms with strong financial foundations and clear paths to growth, investors can uncover...

Simply Wall St. 2 months ago

NVTS

RSKD

CERS
+9.42%
Are Investors Undervaluing Cerus Corporation (NASDAQ:CERS) By 49%?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Cerus fair value estimate is US$2.99 Current share price of...

Simply Wall St. 2 months ago

CERS
+9.42%
Cerus secures CE mark approval for LED-based illumination device

Cerus states that the CE mark represents the first regulatory approval for its “next generation” illuminator.

Medical Device Network 3 months ago

CERS
+9.42%
Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)

CONCORD, Calif., March 05, 2025--Cerus Corporation (Nasdaq: CERS) announced today the CE mark approval of its next-generation LED-based illumination device, or the INT200, for the INTERCEPT Blood System for platelets and plasma under the European Union (EU) Medical Device Regulation (MDR). This approval allows Cerus to market the INT200 throughout the EU and in other regions that recognize the CE mark. Some countries may require additional in-country regulatory approval prior to commercializatio

Business Wire 3 months ago

CERS
+9.42%
Cerus Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Cerus ( NASDAQ:CERS ) Full Year 2024 Results Key Financial Results Revenue: US$180.3m (up 15% from FY 2023). Net loss...

Simply Wall St. 3 months ago

CERS
+9.42%
Cerus Corp (CERS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Positive Cash Flow

Cerus Corp (CERS) reports a 15% increase in annual product revenue and achieves positive adjusted EBITDA, despite challenges in foreign exchange and gross margins.

GuruFocus.com 3 months ago

CERS
+9.42%
Cerus: Q4 Earnings Snapshot

CERS) on Thursday reported a loss of $2.5 million in its fourth quarter. On a per-share basis, the Concord, California-based company said it had a loss of 1 cent. The biomedical products company posted revenue of $50.8 million in the period.

Associated Press Finance 3 months ago

CERS
+9.42%
Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results

CONCORD, Calif., February 20, 2025--Cerus Corporation (Nasdaq: CERS) today announced financial results for its full year and fourth quarter ended December 31, 2024.

Business Wire 3 months ago

CERS
+9.42%
Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference

CONCORD, Calif., February 19, 2025--Cerus Corporation (Nasdaq: CERS) announced today that members of Cerus’ management are scheduled to present at the TD Cowen 45th Annual Health Care Conference on Wednesday, March 5, at 11:10 a.m. EST.

Business Wire 3 months ago

CERS
+9.42%

Performance Overview

Return	CERS	S&P 500 (^GSPC)
YTD	-1.95%	+2.02%
1-Year	-20.11%	+12.09%
3-Year	-69.92%	+45.59%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Cerus Corporation (CERS)

3 Promising Penny Stocks With Market Caps Over $90M

Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan

Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device

When Should You Buy Cerus Corporation (NASDAQ:CERS)?

Cerus Corporation (NASDAQ:CERS) Just Reported, And Analysts Assigned A US$4.25 Price Target

Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates

Cerus: Q1 Earnings Snapshot

Cerus Corporation Announces First Quarter 2025 Financial Results

With 64% ownership, Cerus Corporation (NASDAQ:CERS) boasts of strong institutional backing

Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025

Cerus Leads Our Selection Of 3 Promising Penny Stocks

Are Investors Undervaluing Cerus Corporation (NASDAQ:CERS) By 49%?

Cerus secures CE mark approval for LED-based illumination device

Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)

Cerus Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Cerus Corp (CERS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Positive Cash Flow

Cerus: Q4 Earnings Snapshot

Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results

Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference

Performance Overview